Dare Bioscience is a biopharmaceutical company. Co.'s product, XACIATO™ vaginal gel, is a single-dose prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. Co.'s portfolio includes three product candidates in clinical development: Ovaprene®, a hormone-free, monthly contraceptive; Sildenafil Cream, a proprietary cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring, for the treatment of menopausal symptoms, including vasomotor symptoms, as part of hormone therapy following menopause. We show 27 historical shares outstanding datapoints in our DARE shares outstanding history coverage, used to compute DARE market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing DARE market cap history over the course of time is important for investors
interested in comparing DARE's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of DARE versus a peer is one thing; comparing
DARE market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like DARE can fluctuate over the course of history.
With this page we aim to empower investors researching DARE by allowing them to research the DARE market cap history. |
Free DARE Email Alerts:
Video: The Importance of Market Cap
